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Rationale: To assess the success rate of smoking cessation with the ‘‘minimal
intervention strategy’’ in general practice, and to determine the influence of
spirometry on this success rate.
Methods: Training in smoking cessation advice was given to 16 general practitioners
(GPs). During 12 weeks, these GPs screened their practice population for smoking
habits, the degree of dependence on nicotine, and the motivation to quit smoking.
Patients willing to stop were randomised to a group that underwent a single office
spirometry, or to a control group. The GPs were asked to support the attempts with
the minimal intervention strategy. Success rates were compared after 6, 12 and 24
months.
Results: On a population of 5590 patients, 1206 smokers were identified (22%). To
the vulnerable group, identified following the Prochaska and Di Clemente scheme,
the proposal was made to change smoking behaviour. Two hundred and twenty-one
patients undertook an attempt of smoking cessation. Nicotine replacement therapy
(NRT) or bupropion was prescribed in 51% of the attempts. Sixty-four sustained
quitters were counted after 6 months (29%), 43 after 1 year (19%) and 33 after 2
years (15%). We found a small but statistically non-significant difference in success
rate in favour of the group that underwent office spirometry.
Conclusion: GPs can motivate almost 20% of their smoking population to quit
smoking. The success rate with the minimal intervention strategy was 19% after 1
year and 15% after 2 years. We found no arguments in favour of confronting smokers
with their lung function as a tool for enhancing smoking cessation.
& 2006 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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Spirometry and smoking cessation advice 2013What this paper adds
Some authors state that spirometry could be a tool
to enhance smoking cessation. Most of the papers
about this topic compare ‘‘regular’’ smoking advice
to ‘‘intensive’’ smoking advice, which often in-
cludes lung function testing. The present study
isolates the influence of spirometry on stop smoking
advice as a single variable. It showed a small,
statistically non-significant difference.Introduction
Smoking cessation is an important goal of most
programs for public health.1,2 Indeed, the burden
of cigarette smoking is enormous.2 One of the
diseases strongly associated with the use of tobacco
is COPD.3 In general, the risk of COPD shows in
general a good correlation with the intensity and
duration of cigarette smoking.4 By 2000 COPD has
become the fourth leading cause of mortality
worldwide.5 Until now, smoking cessation is the
only intervention that can delay the progression of
COPD.6
The effectiveness of brief advice for smoking
cessation is well established, but the estimated
success rate differs greatly from one source to
another.7–9 All guidelines for smoking cessation
include case finding and opportunistic advice in a
primary care setting.10–12 The performance of the
involved health care professionals varies probably
with a series of external influences. Assessment of
the implementation of the guidelines can give hints
for further improvement.
Office spirometry is to an ever-increasing extent
available in general practice. The usefulness of this
technique for lung health assessment and for
screening airflow obstruction is documented.13,14
Some authors state that spirometry may be a tool
to enhance smoking cessation.13,15 Confronting
smokers with their abnormal lung function para-
meters should motivate them to quit. However, the
literature about this topic is controversial.16–18 A
recent systematic literature review19 addressed the
question if spirometry can lead to increased
smoking cessation rates. The authors found that
six of the seven selected randomised controlled
trials did not allow for an independent assessment
of the effects of spirometry on smoking cessation
rates. The only study that assessed the indepen-
dent influence of spirometry27 did not obtain
spirometry directly in the primary care setting.
The authors of the Agency for Healthcare Research
and Quality report19 concluded that more researchis needed to determine if spirometry in primary
care office-based settings results in improved rates
of smoking cessation and long-term abstinence.
The aim of the present study was (1) to assess the
implementation of the guidelines for smoking
cessation in the Belgian primary care, and (2) to
determine the influence of one single office
spirometry on the success rate of smoking cessation
in motivated persons.Methods
Sixteen general practitioners (GPs), working at 14
different practices, followed a short training in
giving advice to quit smoking. The Flemish guide-
lines20 were used as a basis for this 4 h course.
Training was given in the motivational interview
and in the minimal intervention strategy (the 5A
model: ask, advise, assess, assist, arrange). The
motivational model of Prochaska and Di Clemente21
was explained, as well as the Fagerstrom Nicotine
Dependence Test22 (FNDT).
Eight of the GPs had received training in
performance and interpretation of spirometry
before,14 using a microspirometer. The eight others
were using a spirometer, but had not received
specific training.
The GPs were asked to screen all their attending
patients above 15 years of age actively for smoking
habits, their degree of dependence to tobacco
(FNDT), and their motivation to quit smoking.
During a 12-week period the GPs used the ‘‘minimal
intervention strategy’’ to enhance smoking cessa-
tion among their smoking patients. The patients
with a motivation in stage 3 (preparation) or 4
(action) in the scheme of Prochaska and Di
Clemente were asked to fix a day to quit smoking,
and a follow-up contact was offered. The GPs were
instructed to prescribe nicotine replacement ther-
apy (NRT) and/or bupropion for those patients
willing to quit. In addition to this ‘‘minimal
intervention’’, these patients were randomised
into a group to perform office spirometry or to a
control group. The randomisation method was
tossing a coin. Doing so, a random sample of the
potential quitters was confronted with their lung
function measurement values and their flow/
volume curve. The GPs were asked to note if these
smokers had a normal lung function or airflow
obstruction (defined as a FEV1/FVCo0.7). Six
months after the stop date, the GPs informed by
telephone if the attempt to quit smoking was still
successful. This telephone round was repeated at
12 and 24 months after the stop date. Sustained
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J. Buffels et al.2014quitters after 2 years were invited to deliver a
urine sample, which was examined for cotinine and
creatinine as a control for the success of smoking
cessation.0
50
100
150
Female 35 79 101 140 104 59 20 11
Male 35 86 126 125 125 88 61 11
1 2 3 4 5 6 7 8
Figure 1 Active smokers by decade of age and by gender.
0%
20%
40%
60%
80%
100%
Tried to stop 5 22 43 66 45 28 11 1
Keep smoking 65 143 184 199 184 119 70 21
1 6 72 3 4 5 8
Figure 2 Stop smoking attempts in % and absolute
number of total smokers, by decade of age.
Table 2 Success rates for smoking cessation in
the practice population, based on a minimal
intervention strategy.
In 1206
smokers
N % of
attempts
% of all
smokers
Tried to quit 221 100 18.3
Success 6M 64 28.9 5.3
Success 12M 43 19.5 3.6
Success 24M 33 14.9 2.7Results
Fifteen GPs provided us with registration results,
after a case finding strategy on their total popula-
tion of 5590 consecutive patients in a 12-week
registration period for smoking habits. They found
1206 smokers (21.6%), 1026 ex smokers (18.4%) and
3358 never smokers (60%)(Table 1). This amount of
smokers is smaller than in the general Belgian
population, where 28.5% smokers are found.23 Many
more men than woman were active smokers. The
gender difference was more important in the older
age groups (Fig. 1).
Only in 34% of the current smokers and in 21% of
the ex smokers the smoking habits were already
filed in the medical records. The FNDT was
performed among 751 smokers (62%). The average
value was 4.4/10 (SD 2.3). The motivation for
smoking cessation was assessed for 741 smokers
(61.4%). For 187 smokers, the GPs found a stage 3
(preparation) or stage 4 (action) motivation to quit
smoking, according to the scheme of Prochaska and
Di Clemente. These 2 stages are appropriate for
smoking cessation. Smokers with less than 10 pack/
years of smoking history were less motivated for
smoking cessation. We found no significant gender
difference for motivation to stop.
The GPs managed to fix a date to try to quit
smoking for 221 patients, or 18.3% of all smokers.
Figure 2 shows the distribution of attempts by age;
the largest amount of smokers trying to quit was
found between 40 and 50 years of age. NRT and/or
bupropion were prescribed for 51% of the candi-
dates, for 12% it was not prescribed, and for 37%
the data are missing. NRT and/or bupropion was
more often prescribed for women (55.8% of the
cases) than for men (47%), and more often for
smokers with more than 10 pack/years (56.2%).Table 1 Results of case finding on smoking
behaviour in 15GP practices.
M % F % Tot
Smokers 658 28.6 548 16.7 1206
Ex smokers 687 29.8 339 10.3 1026
Never smokers 959 41.6 2399 73.0 3358
Totals 2304 100 3286 100 5590Four registration centres failed to provide suc-
cess rates after 6 months. By means of a telephone
survey, we know that at least 64 subjects suc-
ceeded in smoking cessation after 6 months, 43
after 1 year, and 33 after 2 years (Table 2). Eight of
the sustained quitters after 2 years (24.2%) under-
went a cotinine test on urine. All of these revealed
a negative result. On an intention-to-treat basis,
this represents a success rate of 28.9% after 6
months, 19.5% after 12 months and 14.9% after 24
months. Data are missing for 29 attempts (13.1%)
after 6 months, and for 35 subjects (15.8%) after 12
and 24 months.
Table 3 shows the influence of the different
measured variables on the success rate for smoking
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of the gender difference. Eighty-nine smokers were
randomised to undergo a spirometry. Thirty-one
(34.8%) of them succeeded in smoking cessation
after 6 months, 20 (22.5%) after 1 year and 17
(19.1%) after 2 years. These success rates were at
each moment higher than in the group without
spirometry. However, the difference was never
statistically significant. Within the group with
known lung function tests, we found no significant
difference in success rate between smokers with
normal lung function versus smokers with airflow
obstruction. The subjects receiving a prescription
for NRT and/or bupropion showed at each moment
better success rates than the group without
pharmacological intervention. Only after 2 years,
this difference revealed to be statistically signifi-
cant (P ¼ 0:048).Discussion
This study shows that smoking cessation advice can
be readily incorporated in the daily practice of the
Belgian primary care. In a survey by E-mail among
the participating physicians after the registration
period, they stated to feel much more confidentTable 3 Long-term success rate for smoking cessation, i
values, diagnosis of obstructive airway disease, and the u
% Success
Gender Male
6M 28.6
12M 22.7
24M 16.5
Spirometry Yes
6M 34.3
12M 22.5
24M 19.1
OAD? Obstr
6M 33.3
12M 23.3
24M 20.0
NRT/bupropiony R/
6M 37.4
12M 27.3
24M 22.2
OAD ¼ Obstructive Airway Disease.
yNRT ¼ Nicotine Replacement Therapy.about their ability in smoking cessation advice than
before. International guidelines advise to update
the medical records in general practice with the
smoking habits of every patient.10–12 The results of
our survey showed that this goal is not achieved in
the Belgian primary care setting. The participants
stated that the different systems for electronic
medical record paid not enough attention to a
clear, visible notation of smoking behaviour.
It is remarkable that nearly 20% of all identified
smokers undertook an attempt to quit smoking. The
number of attempts exceeded even the number of
smokers presenting with the appropriate motiva-
tional stage, following Prochaska and Di Clemente.
There is only limited evidence for the effectiveness
of stage-based intervention in changing smoking
behaviour.24 The success rates of at least 29% after
6 months, 19% after 1 year and 15% after 2 years in
the present trial exceed those of many other
studies.7 In addition, in our study sample data are
missing for 29–35 attempts, or 13–16%. These
attempts were calculated as relapses.
Several authors state that the use of spirometry
can probably enhance the success rate of smoking
cessation.13,15 This opinion is sustained by the
study of Risser and Belcher25 This author observed
an important difference in success rate between
a group that received immediate feedback aboutn relation to gender, confrontation with lung function
se of nicotine replacement therapy.
P-value
Female
37.9 0.312
22.1 0.994
17.9 0.924
No
29.0 0.670
20.4 0.987
14.0 0.580
Normal
36.7 0.570
22.4 0.850
18.4 0.962
NO R/
29.8 0.119
17.9 0.073
11.9 0.048
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spirometry results, and pulmonary symptoms on
the one hand, and a group with only education on
the other hand. The number of included smokers
(90) was rather low. In contrast, Sippel et al.26
found no improvement of the quitting rate with
additional education with spirometry and carbon
monoxide measurements. An other randomised
trial of smoking cessation interventions by Segnan
et al.27 compared the minimal intervention to
three other arms with repeated counselling, one
of them combined with spirometry. No significantly
different outcome was measured. A recent sys-
tematic review19 conducted by the Agency for
Healthcare Research and Quality of the US con-
cluded that there is little evidence that spirometry
would provide more than small improvements in
smoking cessation. The present study confirms this
conclusion, when spirometry is isolated as a single
intervention. However, we did not look at the kind
of messages that the practitioner delivered to the
patient, while showing the results of the spirome-
try. It is not unreasonable to think that this
communication can play a role in the success rate
of smoking cessation.
The present study did not show different success
rates of smoking cessation for smokers with airflow
obstruction, as compared to smokers with normal
lung function values. This could indicate that the
message of having a normal lung function does not
decrease the motivation to quit smoking. This
seems to be an important conclusion for stop
smoking clinics. However, there may be a lack of
power due to the relatively small number of
smokers with known lung function (n ¼ 80). Several
other studies show good arguments for increased
numbers of sustained quitters among smokers with
airflow limitation.28,29 Moreover, the present study
was not designed to assess the influence of airflow
obstruction on smoking cessation.
The positive effect of prescription of NRT and/or
bupropion on smoking cessation is well documen-
ted.30,31 The present trial can support this state-
ment, although it was not designed to study this
item, and the population was not randomised for
this variable. It is surprising that the positive effect
of pharmacological support has become ever more
important with the time elapsed after the moment
of quitting.
The most striking findings of the present survey
are, first, the ability of a ‘‘minimal intervention
strategy’’ being applied systematically in primary
care to help 18.3% of all smokers to undertake an
attempt for smoking cessation, and second, the
successful attempt of 15% of those smokers to quit
during at least 2 years.Future research in this field should probably
focus on the messages that are delivered during the
counselling and the feedback about the lung
function parameters, and its perception by the
smokers willing to quit.Conclusions
We found no arguments in favour of the use of a
single spirometry to enhance smoking cessation in a
primary care setting. This confirms similar findings
in others studies with spirometry as an isolated
variable. Smoking cessation advice by means of the
‘‘minimal intervention strategy’’ reached a high
success rate in the tested Belgian general practice.
A short training in smoking cessation advice had a
strong positive effect on the self-perceived ability
of the physicians who give this advice in daily
primary care. This study strengthens former find-
ings that training primary care physicians in
smoking cessation advice is highly cost effective.Acknowledgements
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